Literature DB >> 21419546

Use of opioids in long-term management of temporomandibular joint dysfunction.

Gary F Bouloux1.   

Abstract

The long-term treatment of patients with chronic temporomandibular joint dysfunction has been challenging. The long-term use of opioids in these patients can be neither supported nor refuted based on current evidence. However, evidence is available to support the long-term use of opioids in other chronic noncancer pain states with reduced pain, improved function, and improved quality of life. One group of patients with chronic temporomandibular joint pain, for whom both noninvasive and invasive treatment has failed, might benefit from long-term opioid medication. The choices include morphine, fentanyl, oxycodone, tramadol, hydrocodone, and methadone. Adjunct medication, including antidepressant and anticonvulsant drugs, can also be used. The safety of these medications has been well established, but the potential for adverse drug-related behavior does exist, requiring appropriate patient selection, adequate monitoring, and intervention when needed.
Copyright © 2011 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21419546     DOI: 10.1016/j.joms.2010.12.014

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  2 in total

1.  Behavioral testing in rodent models of orofacial neuropathic and inflammatory pain.

Authors:  Agnieszka Krzyzanowska; Carlos Avendaño
Journal:  Brain Behav       Date:  2012-08-15       Impact factor: 2.708

2.  The Impact of Wearing a Face Mask during the COVID-19 Pandemic on Temporomandibular Joint: A Radiological and Questionnaire Assessment.

Authors:  Moath Zuhour; Majid Ismayilzade; Mehmet Dadacı; Bilsev Ince
Journal:  Indian J Plast Surg       Date:  2022-02-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.